Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2000
09/05/2000US6114126 Detection of modulators which suppress activities of myelin glycoprotein; incubation of modulator with myelin glycoprotein, detecting suppression of myelin glycoprotein activity which is the suppression of nerve propagation
09/05/2000US6114123 Mammalian nucleic acid coding a extracellular transport protein; for the classification, diagnosis, prevention, and treatment of cell proliferative and immune defects
09/05/2000US6114115 Detecting heterozygosity or a mutation in heterozygous form in a sample; labeling nucleic acids, denaturing nucleic acids, incubating with nucleic acid binding protein, detecting bound heteroduplexes
09/05/2000US6114114 Comparative gene transcript analysis
09/05/2000US6114110 Isolation and propagation of a human herpesvirus derived from AIDS-associated Kaposi's sarcoma cells
09/05/2000US6114109 Viral (HIV) growth inhibition
09/05/2000US6113907 Pharmaceutical grade St. John's Wort
09/05/2000US6113903 Antidiabetic agents
09/05/2000US6113902 Polypeptides with amino acid sequences of pro-lys-ile and cyclic epitopes
09/05/2000US6113899 Antagonists of chaperonin 10
09/05/2000US6113897 Antibodies and their use
09/05/2000US6113889 Isolated hair follicle without dermal papilla; alopecia
09/05/2000US6113878 Scintigraphy
09/05/2000US6113877 σ-2 receptors as biomarkers of tumor cell proliferation
09/05/2000US6113859 Bar-type NOx gas sensor having WO3 sensing film
09/05/2000US6113856 Immobilizing a ph indicator containing an ionizable phenol group and a negatively charged group in a solid matrix polymer to which quaternary ammonium groups are covalently bound
09/05/2000US6113816 Kit for conducting an assay to detect a substance using enzymatically-induced decomposition of dioxetanes
09/05/2000US6113768 Ultraminiaturized surface structure with controllable adhesion
09/05/2000US6113763 Method for measuring cellular chemical profiles
09/05/2000US6112602 Without chromatographic separation; adsorbent trap is used to adsorb the voc contaminants, while venting out permanent gases, such as carbon dioxide and methane; then voc's are rapidly desorbed and carried to a detector for measuring
09/05/2000US6112599 Method and apparatus for measuring a cement sample using a single transducer assembly
09/05/2000US6112573 Process for determining the lubricant power of lubricant oils
09/05/2000CA2245050C Three-electrode electrochemical gas sensor
09/05/2000CA2174193C Blood collection assembly including clot-accelerating glass insert
09/05/2000CA2057058C Monoclonal antibodies to c-reactive protein
09/05/2000CA2047685C Purified insulin mediators and purification process for same
09/05/2000CA1341094C Diagnosis for malignant hyperthermia
09/01/2000CA2290149A1 Device for carrying out lateral-flow assays involving more than one analyte
08/2000
08/31/2000WO2000051191A1 A hybrid electrical device with biological components
08/31/2000WO2000050904A1 Test kit for analysing factor viii-splitting protease
08/31/2000WO2000050903A1 Particulate solid phase immobilized protein quantitation
08/31/2000WO2000050902A2 High throughput assay based on the use of a polypeptide binding pair
08/31/2000WO2000050901A1 Protein assay
08/31/2000WO2000050900A2 Methods and compositions for diagnosing carcinomas
08/31/2000WO2000050899A1 Staging of prostate cancer
08/31/2000WO2000050898A1 Method for presuming restenosis following coronary vessel intervention
08/31/2000WO2000050897A1 Compounds and methods for the detection and prevention of t. cruzi infection
08/31/2000WO2000050896A1 Compositions and methods for monitoring the modification of engineered binding partners
08/31/2000WO2000050895A1 Isolating a cytoplasmic fraction without impairing the viability of oocytes and embryonic cells
08/31/2000WO2000050894A1 Oil quality sensor and method for producing the same
08/31/2000WO2000050893A1 Method for the spectroscopic determination of the concentration of alcohols with 1 to 5 carbon atoms
08/31/2000WO2000050892A1 An in vivo and in vitro model for cutaneous photoaging and oxidative damage
08/31/2000WO2000050891A1 Analyzing strip having a fluid cell and a method of analyzing a sample
08/31/2000WO2000050889A1 System and method for managing and presenting information derived from gene expression profiling
08/31/2000WO2000050883A1 Method and device for determining metallic contaminant particles in lubricating grease
08/31/2000WO2000050881A1 Method for determining the concentration of hot gases in an oxygen-containing medium
08/31/2000WO2000050874A1 Method and arrangement for measuring the calorific value and/or the wobbe index of combustible gas, especially natural gas
08/31/2000WO2000050873A1 Method and device for candling eggs
08/31/2000WO2000050872A2 A system for cell-based screening
08/31/2000WO2000050868A2 Generation of diagnostic tools to assay the human lhx3/p-lim/lim-3 factor
08/31/2000WO2000050865A1 Method and apparatus for determining non-linear shrinkage on the basis of the tension profile
08/31/2000WO2000050646A1 Methods of screening for antiviral compounds
08/31/2000WO2000050641A1 T CELL RECEPTOR Vβ-Dβ-Jβ SEQUENCE AND METHODS FOR ITS DETECTION
08/31/2000WO2000050635A1 Methods and compositions using binding partners
08/31/2000WO2000050633A1 Method for cloning signal transduction intermediates
08/31/2000WO2000050631A2 Compositions and methods for monitoring the modification of natural binding partners
08/31/2000WO2000050630A2 Assay for measuring different enzyme activities simultaneously
08/31/2000WO2000050629A2 Diagnostic and screening method for male infertility
08/31/2000WO2000050626A1 Methods for making morpholino-nucleotides, and their use for analysing and marking nucleic acid sequences
08/31/2000WO2000050618A1 Virus vector
08/31/2000WO2000050608A1 Novel polypeptide
08/31/2000WO2000050607A2 Goodpasture antigen binding protein
08/31/2000WO2000050596A2 14273 receptor, a novel g-protein coupled receptor
08/31/2000WO2000050590A1 Mdm interacting protein and methods of use thereof
08/31/2000WO2000050580A2 Composition, methods and reagents for the synthesis of a soluble form of human phex
08/31/2000WO2000050574A1 Compositions and methods for modulating serum cholesterol
08/31/2000WO2000050565A2 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
08/31/2000WO2000050562A2 Dna encoding snorf25 receptor
08/31/2000WO2000050460A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses
08/31/2000WO2000050454A1 Androgen-induced suppressor of cell proliferation and uses thereof
08/31/2000WO2000050453A1 A novel inhibitor of programmed cell death
08/31/2000WO2000050450A1 Mite protein
08/31/2000WO2000050446A1 Oligopeptide derivatives for the electrochemical measurement of protease activity
08/31/2000WO2000050445A1 Novel component of von hippel-lindau tumor suppressor complex and scf ubiquitin ligase
08/31/2000WO2000050399A1 Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy
08/31/2000WO2000050175A1 Apparatus and method for handling magnetic particles in a fluid
08/31/2000WO2000050093A1 Method of measuring physiological function
08/31/2000WO2000050081A1 Product and method for treatment of conditions associated with receptor-desensitization
08/31/2000WO2000050062A2 Methods and compositions for altering mucus secretion
08/31/2000WO2000049941A1 Glucose monitor calibration methods
08/31/2000WO2000049876A1 System and method for evaluating agents which prevent oxidative damage
08/31/2000WO2000049867A2 Synthesis of the first paramagnetic and active analogue (epm-2) of the melanocyte stimulating hormone
08/31/2000WO2000043492A8 Method of site specific labeling of proteins and uses therefor
08/31/2000WO2000032632A3 Allo- and auto-reactive t-cell epitopes from rhesus protein and their use
08/31/2000WO2000028038A3 Virulence genes and proteins, and their use
08/31/2000WO2000028029A3 Cell surface glycoproteins
08/31/2000WO2000026664A3 Assaying
08/31/2000WO2000026236A3 Method of modulating cell differentiation or neoplastic transformation by altering cadherin-11 expression or function
08/31/2000WO2000025805A8 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2
08/31/2000WO2000023465A3 Methods and reagents for isolating biologically active peptides
08/31/2000WO2000019823A9 Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof
08/31/2000WO2000019200A9 Identifying agents that alter mitochondrial permeability transition pores
08/31/2000WO2000018949A9 Delivery of phosphoinositide polyphosphates into cells
08/31/2000WO2000018923A9 Slgp protein and nucleic acid molecule and uses therefor
08/31/2000WO2000018910A9 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
08/31/2000WO2000018803A3 Antibodies to mammalian langerhans cell antigen and their uses
08/31/2000WO2000018795A9 Compositions and methods for wt1 specific immunotherapy
08/31/2000WO2000018289A9 Method and device for predicting physiological values
08/31/2000WO2000017103A3 Inventory control
08/31/2000WO2000013022A9 Methods for the temporal analysis of programmed cell death in living cells
1 ... 3079 3080 3081 3082 3083 3084 3085 3086 3087 3088 3089 3090 3091 3092 3093 3094 3095 3096 3097 3098 3099 ... 3937